www bzfxw com BRITISH STANDARD BS EN 724 1995 Guidance on the Application of EN 29001 and EN 46001 and of EN 29002 and EN 46002 for non active medical devices The European Standard EN 724 1994 has the[.]
Trang 2This British Standard, having
been prepared under the
direction of the Health and
Environment Sector Board, was
published under the authority
of the Standards Board and
comes into effect on
15 April 1995
© BSI 11-1998
The following BSI references
relate to the work on this
standard:
Committee reference HCC/66
Draft for comment 92/52898 DC
The preparation of this British Standard was entrusted to Technical Committee HCC/66, Quality systems for the manufacture of medical devices, upon which the following bodies were represented:
Association of British Certification BodiesAssociation of British Health-care IndustriesAssociation of Contact Lens ManufacturersAssociation of X-ray Equipment Manufacturers (BEAMA Ltd.)British Anaesthetic and Respiratory Equipment Manufacturers’ AssociationBritish In Vitro Diagnostics Association
British Orthopaedic AssociationBritish Surgical Trades AssociationDental Laboratories Association LimitedDepartment of Health
Electro Medical Trade Association LimitedGAMBICA (BEAMA Ltd.)
Guild of Hospital PharmacistsInstitute of Physical Sciences in Medicine (ISPM)Institute of Quality Assurance
Medical Sterile Products AssociationSurgical Dressings Manufacturers’ Association
Amendments issued since publication
Trang 4This British Standard has been prepared by Technical Committee HCC/66 and is
the English language version of EN 724:1994 Guidance on the application of
EN 29001 and EN 46001 and of EN 29002 and EN 46002 for non-active medical devices, published by the European Committee for Standardization (CEN).
BS EN 724 provides guidance on the operation of quality management systems used in the manufacture of non-active medical devices A similar standard,
BS EN 501031), covers guidance for the manufacture of active medical devices including active implantable medical devices In addition another standard,
BS EN 928, which will provide guidance on quality management systems used in the manufacture of in vitro diagnostic devices, is in preparation
Cross-references Publication referred to Corresponding British Standard
BS 5750 Quality systems
EN 29001:19872) Part 1:1987 Specification for design/development,
production, installation and servicing
EN 29002:19872) Part 2:1987 Specification for production and installation
EN 29004:19872) Part 0: Principal concepts and applications
Section 0.2:1987 Guide to quality management and
quality system elements
EN 46001:1993 BS EN 46001:1994 Specification for application of
EN 29001 (BS 5750-1) to the manufacture of medical devices
EN 46002:1993 BS EN 46002:1994 Specification for application of
EN 29002 (BS 5750-2) to the manufacture of medical devices
A British Standard does not purport to include all the necessary provisions of a contract Users of British Standards are responsible for their correct application
Compliance with a British Standard does not of itself confer immunity from legal obligations.
1) In preparation.
2) For information, since the ratification of this European Standard, EN 29001:1987,
EN 29002:1987 and EN 29004:1987 have been superseded by EN ISO 9001:1994,
EN ISO 9002:1994 and EN ISO 9004-1:1994 The corresponding British Standards are
Trang 5Guide d’application des EN 29001 et
EN 46001 et des EN 29002 et EN 46002 pour
les dispositifs médicaux non actifs
Anleitung zur Anwendung von EN 29001 und
EN 46001 und von EN 29002 und EN 46002 für nicht-aktive Medizinprodukte
This European Standard was approved by CEN on 1994-10-27 CEN members
are bound to comply with the CEN/CENELEC Internal Regulations which
stipulate the conditions for giving this European Standard the status of a
national standard without any alteration
Up-to-date lists and bibliographical references concerning such national
standards may be obtained on application to the Central Secretariat or to any
CEN member
This European Standard exists in three official versions (English, French,
German) A version in any other language made by translation under the
responsibility of a CEN member into its own language and notified to the
Central Secretariat has the same status as the official versions
CEN members are the national standards bodies of Austria, Belgium,
Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy,
Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and
Trang 6Foreword
This European Standard was prepared by the
Technical Committee CEN TC 205, Non-active
medical devices, the Secretariat of which is held by
BSI
This European Standard has been prepared under a
Mandate given to CEN by the European
Commission and the Secretariat of the European
Free Trade Association, and supports essential
requirements of EC Directive(s)
This European Standard shall be given the status of
a National Standard, either by publication of an
identical text or by endorsement, at the latest by
April 1995, and conflicting national standards shall
be withdrawn at the latest by April 1995
Annexes designated informative are given only for
information In this standard annexes A, B and C
are informative
According to the CEN/CENELEC Internal
Regulations, the following countries are bound to
implement this European Standard: Austria,
Belgium, Denmark, Finland, France, Germany,
Greece, Iceland, Ireland, Italy, Luxembourg,
Netherlands, Norway, Portugal, Spain, Sweden,
Switzerland, United Kingdom
4.8 Product identification and traceability 9
4.11 Inspection, measuring and test
4.13 Control of nonconforming product 12
Annex B (informative) Features of job descriptions of key individuals 20Annex C (informative) Bibliography 21
Trang 7Introduction
This European Standard has been written to give
guidance to organizations providing a non-active
medical device who wish to ensure that they will
comply with EN 29001/EN 29002 and the particular
requirements given in EN 46001/EN 46002 It is
also intended to provide guidance for certifying and
regulatory bodies The guidance in this standard for
the fulfilment of requirements should always be in
relation to the products being manufactured and
interpreted accordingly
This standard needs to be read in conjunction with
the EN 29000 series of standards with which
compliance is sought This standard is not intended
as a replacement for EN 29004 which has its own
very distinct relationship with the EN 29000 series
of standards
The combination of EN 29001/EN 46001 and
EN 29002/EN 46002 embraces the principles of
Good Manufacturing Practices (GMP) which have
been in operation in the manufacture of non-active
medical devices for a number of years
This document seeks to assist in the transition
from GMP to quality systems by presenting familiar
concepts under the relevant paragraphs of
EN 29001/EN 46001 and EN 29002/EN 46002
The references which have been made to EN 29004
are not necessarily exhaustive but seek to identify
sections of EN 29004 with particular relevance to
the guidance in this document Consideration of this
document alone is not an alternative to
understanding EN 29004 and it is therefore
recommended that EN 29004 is first read and
understood in its entirety For ease in the use of this
standard, references to clauses in EN 29004 have
been cited within the framework of EN 29001 and
EN 29002
Annex A to this European Standard provides
additional guidance on those elements of quality
systems to which particular emphasis should be
placed for medical devices which are supplied either
sterile or to a defined standard of microbial or
particulate cleanliness The guidance in annex A is
intended to be considered in addition to that
provided in the body of the standard
1 Scope
This European Standard provides guidance on the
establishment and maintenance of the quality
systems specified in EN 29001/EN 46001 or
EN 29002/EN 46002 for the manufacture of
non-active medical devices It does not add to, or
otherwise change, the requirements of those
standards and is not intended to be used for the
assessment of a manufacturer’s quality system
This European Standard provides examples of how
to meet the requirements, recognizing that other methods which achieve the same ends are equally acceptable; gives general advice on how to meet the requirements; and draws attention to aspects of requirements that may not be readily apparent to those unfamiliar with quality systems for non-active medical devices
Annex A to this European Standard provides guidance on the elements of quality systems which are relevant to the manufacture of medical devices which are to be supplied either sterile or at a defined level of microbiological or particulate cleanliness
The adoption of systems other than those described
in this European Standard is not to be regarded as
a non-compliance with EN 29001 and EN 29002 and/or the specific requirements in EN 46001 and
EN 46002
2 Normative references
This European Standard incorporates, by dated or undated reference, provisions from other
publications These normative references are cited
at the appropriate places in the text and the publications are listed hereafter For dated references, subsequent amendments to or revisions
of any of these publications apply to this European Standard only when incorporated in it by
amendment or revision For undated references the latest edition of the publication referred to applies
EN 29001:1987, Quality systems — Model for
quality assurance in design/development, production, installation and servicing.
EN 29002:1987, Quality systems — Model for
quality assurance in production and installation.
EN 29004:1987, Quality management and quality
system elements — Guidelines.
EN 46001:1993, Quality systems — Medical
devices — Particular requirements for the application of EN 29001.
EN 46002:1993, Quality systems — Medical
devices — Particular requirements for the application of EN 29002.
3 Definitions
For the purpose of this standard the definitions given in EN 46001 and EN 46002 apply, together with the following:
3.1 contract
any agreement between the supplier and the purchaser concerning the supply of product
NOTE A contract may be in writing, verbal, or a combination of both.
Trang 8any of the following apply:
a) requirements prescribed by the purchaser and
agreed by the supplier in a contract for product;
b) requirements prescribed by the supplier which
are perceived as satisfying a market need; or
c) regulatory requirements
3.5
validation
exercise of carrying out a programme designed and
documented to demonstrate that a process,
operating within specified limits, will consistently
produce product or services complying with
predetermined requirements
NOTE Validation is considered as a total process which consists
of:
a) obtaining and documenting evidence that the installation of
equipment follows design intentions and that the equipment
as installed will perform consistently within predetermined
limits (commissioning); and
b) obtaining and documenting evidence that the equipment as
installed and operated in accordance with process
specifications will function reliably, produce acceptable
product or services, and that key process variables are known
Guidance for clauses 4.1.1 of EN 29001 and
EN 46001 and for clauses 4.1.1 of EN 29002 and
EN 46002.
When defining and documenting the supplier’s
quality policy, commitment and objectives, the
management should express the policy in language
that the staff can understand The policy should be
specific to the product supplied and to the staff
employed
Management should be seen to demonstrate
commitment to their quality policy both actively and
on a continuing basis
For general guidance see 4.1, 4.2, 4.3 and 4.4.4 of
EN 29004
4.1.2 Organization
4.1.2.1 Responsibility and authority
Guidance for clauses 4.1.2.1 of EN 29001 and
EN 46001 and for clauses 4.1.2.1 of EN 29002 and
a) product meets specified requirements;
b) documented quality systems, standards and specifications are maintained; and
c) regular internal quality audits are performed
The responsibility for quality assurance and production should be assigned to separate individuals Annex B to this European Standard provides an example of the features of a job description for these individuals
Particular guidance on responsibility and authority for the manufacture of sterile products, or other products for which the microbiological cleanliness is
of significance, is provided in annex A
Deputies for the key individuals identified above should be nominated and be capable of assuming the responsibilities when necessary
For general guidance, see also 5.2.1, 5.2.2 and 5.2.3
of EN 29004
4.1.2.2 Verification resources and personnel
Guidance for clauses 4.1.2.2 of EN 29001 and
EN 46001 and for clauses 4.1.2.2 of EN 29002 and
EN 46002.
The resources which need to be provided may include personnel trained in specific disciplines, for example materials science, microbiology or
statistics
For general guidance, see also 5.2.4 and 18.3 of
EN 29004
Trang 94.1.2.3 Management representative
Guidance for clauses 4.1.2.3 of EN 29001 and
EN 46001 and for clauses 4.1.2.3 of EN 29002 and
EN 46002.
If the management representative (see also 4.1.2.1)
who has the responsibility for the quality system
has other functions to perform, there should be no
conflict of interest
4.1.3 Management review
Guidance for clauses 4.1.3 of EN 29001 and
EN 46001 and for clauses 4.1.3 of EN 29002 and
EN 46002.
For general guidance, see 5.5 of EN 29004.
4.2 Quality system
Guidance for clauses 4.2 of EN 29001 and EN 46001
and for clauses 4.2 of EN 29002 and EN 46002.
The main document in the quality system is usually
a quality manual This documents quality policy
and describes the quality system The quality
manual is usually supported by detailed procedures,
work instructions and specifications for product and
processes Such supporting documents themselves
are generally not within the quality manual because
of the frequency at which they may be subject to
change
EN 46001 and EN 46002 require that
documentation supporting the quality manual is
organized in a file for each product type Such files
may be referred to as “Device Master File” or
“Device Master Record” This can contain, or give
reference to the location of, documentation relevant
to the manufacture of that product Examples of
such documentation may include:
— specifications for raw materials, labelling,
packaging materials, intermediate and finished
products;
— drawings;
— work instructions, including equipment
operation;
— sterilization process details, if applicable;
— inspection procedures and acceptance criteria
Such files may also contain quality records
(see 4.16) such as:
— design verification records;
— process validation records
All this documentation forms part of the quality
system and should be subject to document control
— product description, quantity and price;
NOTE The relationship between the supplier and the
sub-contractor is covered by 4.6 of EN 29001 and this standard. 4.4 Design control
4.4.1 General Guidance for clauses 4.4.1 of EN 29001 and
EN 46001; not applicable to EN 29002 and
EN 46002.
The design phase takes a product from concept to production and is an important phase in the life cycle of a medical device The essential quality aspects of safety, performance and reliability of a device are established during this phase Therefore, adequate design controls should be established and implemented to ensure these aspects are met prior
to production One of the major causes of quality problems leading to device recalls and failures is deficient design
For general guidance see also 8.1 and clause 19 of
For general guidance, see also 8.2.1, 8.2.2 and 8.2.3
of EN 29004
4.4.2.1 Activity assignment
Guidance for clauses 4.4.2.1 of EN 29001 and
EN 46001; not applicable to EN 29002 and
EN 46002
For general guidance, see 8.2.1 and 8.2.2 of
EN 29004
Trang 104.4.2.2 Organizational and technical interfaces
Guidance for clauses 4.4.2.2 of EN 29001 and
EN 46001; not applicable to EN 29002 and
EN 46002.
When input to the design is from a variety of
sources, such as from personnel from different
functions and/or disciplines within or external to the
supplier’s organization or from individuals with
specialist expertise, the inter-relationship or
interfaces should be clearly understood and
controlled
For general guidance see also clause 7 of EN 29004.
4.4.3 Design input
Guidance for clauses 4.4.3 of EN 29001 and
EN 46001; not applicable to EN 29002 and
EN 46002.
Design input is typically in the form of a
performance specification and/or a product
description Design input should be specified to the
level of detail necessary to permit the design activity
to be carried out effectively, and to provide a
consistent basis for design decisions, design
verification and design changes
Design input data may include a product brief and
performance requirements, together with
requirements of regulations, harmonized European
Standards and other published technical standards
Design input data may also include advice from an
appropriately qualified practitioner For example,
consideration may need to be given to anatomical
and physiological implications of the intended use of
the product
For general guidance, see also clauses 7, 8.2.4
and 8.2.5 of EN 29004.
4.4.4 Design output
Guidance for clauses 4.4.4 of EN 29001 and
EN 46001; not applicable to EN 29002 and
EN 46002.
The design output documents include typically:
— product specifications and drawings;
— manufacturing specifications and drawings
They should:
— be able to be related to the design input and
permit design verification;
— identify aspects which affect safety,
performance and reliability;
— be maintained as quality records
(see also 4.16).
4.4.5 Design verification Guidance for clauses 4.4.5 of EN 29001 and
EN 46001; not applicable to EN 29002 and
EN 46002.
Design verification should be a formal procedure A detailed, documented description of the design verification programme should be established, including organizational functions involved, procedures and methods to be used, documentation required, and variables to be considered and evaluated
The extent of design verification required is a function of the safety, performance and the reliability requirements for the item under consideration, the complexity of the design, the existence of published technical standards, the state
of the art and the similarity with previously proven designs Should the person(s) responsible for design verification decide that certain aspects or
parameters related to safety, performance and reliability do not need to be verified, the decision should be properly reasoned and recorded
Upon completion of design verification activities, the final design configuration is documented and manufacturing specifications established prior to release to production For any subsequent design
design review meetings are retained (see 4.16)
and usually identify those present and decisions reached
b) Qualification tests and demonstrations
Once the design is translated into physical form, its safety, performance and reliability should be verified by testing under simulated use
conditions Such verification may include in vitro and/or in vivo testing
Clinical evaluation may be required as part of the design verification activities The general guidance presented here also embraces any clinical evaluations within the quality system
The conduct of the clinical investigation of medical devices is the subject of a harmonized European Standard (EN 540)
c) Alternative calculations
The appropriateness of any alternative calculation method should be reviewed
Trang 11d) Design comparison
Design comparison may be applicable when:
— a new application is identified for a proven
Guidance for clauses 4.4.6 of EN 29001 and
EN 46001; not applicable to EN 29002 and
EN 46002.
Design changes may be necessary as a result of:
— experience in use;
— change in market requirements;
— change in regulatory or safety requirements;
— corrective action (see 4.14).
Any changes to design inputs should be identified
and reviewed by the supplier to determine whether
they affect previously approved design verification
results Design changes in one component of a
product should be evaluated for their effects on the
whole Improving one characteristic may have
unforeseen effects on another The design and
verification procedures should also be reviewed and
modified as necessary where a significant design
change arises because of an incorrect design
For general guidance, see also 8.8 of EN 29004.
4.5 Document control
Guidance for clauses 4.5 of EN 29001 and EN 46001
and for clauses 4.4 of EN 29002 and EN 46002.
For general guidance, see 17.1 and 17.2 of
EN 29004
4.5.1 Document approval and issue
Guidance for clauses 4.5.1 of EN 29001 and
EN 46001 and for clauses 4.4.1 of EN 29002 and
EN 46002.
Care and attention to detail should be taken in
preparing all documents, particularly in ensuring
that the information given is unambiguous and can
be understood by the persons who are going to use
them
Document control procedures may be assisted by the
adoption of a consistent structure for the documents
within the quality system Each document should be
paginated to ensure that the total document is
available and should state:
— title and scope;
— date of issue;
— revision status;
— the originator;
— the person(s) approving it;
— the person(s) issuing it
The document control procedure should:
— include periodic review of documents;
— assign responsibilities for preparation, check, release and issue;
— require review of all quality-related documents for accuracy, completeness and correctness before approval and issue;
— identify recipients of controlled copies of documents;
— ensure that documents which are not controlled are clearly marked indicating that these are not subject to updating;
— ensure prompt withdrawal of obsolete copies of
controlled documents (see 4.5.2 of this standard);
— define the method for recording the implementation date of a document change
4.5.2 Document changes/modifications Guidance for clauses 4.5.2 of EN 29001 and
EN 46001 and for clauses 4.4.2 of EN 29002 and
in accordance with the defined approval and issuing procedure For example, a raw material
specification change could apply to a number of different products
The date of the implementation of the change should
be recorded
The master copy of withdrawn documents should be clearly marked and retained by storage in a secure location Other copies of withdrawn documents should be disposed of The object of retaining a single copy of obsolete or superseded documents is to provide a full picture of the product at various stages of its life, from first design considerations through development to present status
Trang 124.6 Purchasing
4.6.1 General
Guidance for clauses 4.6.1 of EN 29001 and
EN 46001 and for clauses 4.5.1 of EN 29002 and
EN 46002.
A supplier may purchase, from a number of sources,
products and services which may include:
— raw materials;
— components or sub-assemblies manufactured
by others using equipment owned by, and/or
materials provided by, the supplier;
— components or sub-assemblies available as
standard items from other sources;
— components or sub-assemblies manufactured
by others to the supplier’s specifications;
— completed product bearing the mark and/or
name of the supplier; this may be ready for sale or
require some further processing such as
packaging and/or sterilization;
— services, e.g sterilization, calibration, testing,
pest control, waste disposal, cleaning,
environmental monitoring, laundry, transport,
installation
EN 29001 and EN 46001 use the term
“sub-contractor” to include all providers of
materials, components, sub-assemblies, finished
products or services However, a broad division can
be made between purchase of materials or services
to the supplier’s specification and the purchase of
standard commercially available items This can be
useful in deciding on the type and extent of control
to be applied to purchased materials or services
For general guidance, see also 9.1, 9.5 and 9.6 of
EN 29004
4.6.2 Assessment of sub-contractors
Guidance for clauses 4.6.2 of EN 29001 and
EN 46001 and for clauses 4.5.2 of EN 29002 and
EN 46002.
The selection of providers of products or services
consists of establishing criteria, making an initial
selection, and subsequent formal assessment of
capability; sub-contractors should be subjected to an
on-going surveillance and monitoring of
performance
All providers of products and services should be able
to meet the needs of the supplier The criteria which
form the basis for the assessment of potential
candidates should be established
The supplier should be able to demonstrate that the system provides for:
— formal consideration of the extent of assessment required;
— selection based on a sufficiently structured appraisal appropriate to the product or service procured;
— periodic reassessment of performance;
— due account of the results of surveillance when re-ordering
Surveillance may consist of one or more of the following activities
a) For a provider of standard, commercially available, products or services:
— periodic inspection of products or services received;
— monitoring of inspection results;
— accepting certification of the sub-contractor’s quality system by third parties;
— accepting certificates of conformance and/or
of analysis from the sub-contractor
b) For a provider of products or services to the specification of the supplier:
— auditing of the quality system by the supplier, in addition to the items listed in a) above
For general guidance, see also 9.3 of EN 29004 4.6.3 Purchasing data
Guidance for clauses 4.6.3 of EN 29001 and
EN 46001 and for clauses 4.5.3 of EN 29002 and
EN 46002.
For general guidance, see 9.2 and 9.4 of EN 29004 4.6.4 Verification of purchased product
Guidance for clauses 4.6.4 of EN 29001 and
EN 46001 and for clauses 4.5.4 of EN 29002 and
EN 46002.
This requirement of EN 29001 applies when the purchaser is the customer for the product which the
supplier manufactures (see clause 3).
4.7 Purchaser supplied product
Guidance for clauses 4.7 of EN 29001 and EN 46001 and for clauses 4.6 of EN 29002 and EN 46002.
This subclause applies when the purchaser provides items to the supplier to be incorporated by the supplier into the completed product or service For example, the purchaser may provide items to the supplier for inclusion into a kit or set In such cases, the supplier should not knowingly incorporate nonconforming parts into the product or service
Trang 134.8 Product identification and traceability
Guidance for clauses 4.8 of EN 29001 and EN 46001
and for clauses 4.7 of EN 29002 and EN 46002.
a) Identification
Identification of raw materials, components and
finished products is important for a number of
It is usual for finished products to be identified
by a batch/lot number or serial number The
extent to which raw materials and components
need to be identified and related to the finished
product batch/lot or serial number will depend
upon a number of factors including:
— the material involved;
— the type of finished product;
— the effect of failure of finished product or
materials used therein;
Batch/lot or serial numbers on products permit
traceability in two directions: forward to
purchasers and backward to raw materials,
components and processes used in manufacture
The former is important if it is necessary to trace
products to the user, e.g patients or hospitals,
and the latter enables investigation of quality
problems and feedback for the prevention of
nonconforming product
Where in-plant traceability of raw materials and
components is important to quality, appropriate
identification should be maintained throughout
the production process to ensure traceability to
original material identification and quality
status
The supplier should establish and maintain a
forward traceability system up to the point when
products leave the suppliers’ possession
For general guidance, see also 11.2 of EN 29004.
Particular guidance on process control for the manufacture of sterile products, or other products for which the microbiological cleanliness is of significance, is provided in annex A
For general guidance, see 10.1.1, 10.1.5, 10.2, 10.3, 11.3 , 11.5, and 11.6 of EN 29004.
a) Production processes
Manufacture begins with the issue of raw materials and provision of equipment and continues through all subsequent stages of production until the finished product is released for sale
A documented procedure should be agreed for each stage of manufacture This may include:
— equipment and materials to be used;
— precautions to be taken;
— step by step instructions;
— any in-process quality checks conducted by production personnel;
— the procedure to be followed in the event of quality problems;
— the disposition of accepted or rejected products
Before and during the introduction of a new
design of product (see also 4.4 of this standard)
the manufacturing process, including any new manufacturing and test methods, should be fully evaluated The key variables and acceptance limits should be identified and validated for processes, test methods and sampling plans Similar procedures should be followed where any significant change in processing occurs The results of validation exercises should be documented and processes should undergo a regular critical appraisal to ensure that they remain capable of achieving the intended results